Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 More extended-spectrum beta-lactamases.

Literature DB >> 1952834

More extended-spectrum beta-lactamases.

G A Jacoby¹, A A Medeiros.

Abstract

Mesh：

Substances：

Year: 1991 PMID： 1952834 PMCID： PMC245253 DOI： 10.1128/AAC.35.9.1697

Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN： 0066-4804 Impact factor: 5.191

× No keyword cloud information.

72 in total

1. TEM-E1: a novel beta-lactamase conferring resistance to ceftazidime.

Authors: D J Payne; M S Marriott; S G Amyes
Journal: FEMS Microbiol Lett Date: 1989-05 Impact factor: 2.742

2. In vivo selection of a cephamycin-resistant, porin-deficient mutant of Klebsiella pneumoniae producing a TEM-3 beta-lactamase.

Authors: B Pangon; C Bizet; A Buré; F Pichon; A Philippon; B Regnier; L Gutmann
Journal: J Infect Dis Date: 1989-05 Impact factor: 5.226

3. Interactions of new plasmid-mediated beta-lactamases with third-generation cephalosporins.

Authors: R Labia; A Morand; K Tiwari; J Sirot; D Sirot; A Petit
Journal: Rev Infect Dis Date: 1988 Jul-Aug

4. Plasmid-mediated beta-lactamase (TEM-7) involved in resistance to ceftazidime and aztreonam.

Authors: L Gutmann; M D Kitzis; D Billot-Klein; F Goldstein; G Tran Van Nhieu; T Lu; J Carlet; E Collatz; R Williamson
Journal: Rev Infect Dis Date: 1988 Jul-Aug

5. Novel plasmid-mediated beta-lactamase from Escherichia coli that inactivates oxyimino-cephalosporins.

Authors: Y Matsumoto; F Ikeda; T Kamimura; Y Yokota; Y Mine
Journal: Antimicrob Agents Chemother Date: 1988-08 Impact factor: 5.191

6. Characterization of the plasmid genes blaT-4 and blaT-5 which encode the broad-spectrum beta-lactamases TEM-4 and TEM-5 in enterobacteriaceae.

Authors: W Sougakoff; A Petit; S Goussard; D Sirot; A Bure; P Courvalin
Journal: Gene Date: 1989-05-30 Impact factor: 3.688

7. Plasmid-mediated beta-lactamases in clinical isolates of Klebsiella pneumoniae and Escherichia coli resistant to ceftazidime.

Authors: A Vuye; G Verschraegen; G Claeys
Journal: Antimicrob Agents Chemother Date: 1989-05 Impact factor: 5.191

8. SHV-5, a novel SHV-type beta-lactamase that hydrolyzes broad-spectrum cephalosporins and monobactams.

Authors: L Gutmann; B Ferré; F W Goldstein; N Rizk; E Pinto-Schuster; J F Acar; E Collatz
Journal: Antimicrob Agents Chemother Date: 1989-06 Impact factor: 5.191

9. Dissemination in five French hospitals of Klebsiella pneumoniae serotype K25 harbouring a new transferable enzymatic resistance to third generation cephalosporins and aztreonam.

Authors: A Buré; P Legrand; G Arlet; V Jarlier; G Paul; A Philippon
Journal: Eur J Clin Microbiol Infect Dis Date: 1988-12 Impact factor: 3.267

Review 10. [Plasmid resistance to 3d generation cephalosporins].

Authors: A Philippon; G Paul; G Vedel; P Nevot
Journal: Presse Med Date: 1988-10-26 Impact factor: 1.228

210 in total

1. In vitro and in vivo activities of amikacin, cefepime, amikacin plus cefepime, and imipenem against an SHV-5 extended-spectrum beta-lactamase-producing Klebsiella pneumoniae strain.

Authors: D Szabó; A Máthé; Z Filetóth; P Anderlik; L Rókusz; F Rozgonyi
Journal: Antimicrob Agents Chemother Date: 2001-04 Impact factor: 5.191

2. SHV-13, a novel extended-spectrum beta-lactamase, in Klebsiella pneumoniae isolates from patients in an intensive care unit in Amsterdam.

Authors: M Yuan; L M Hall; P H Savelkoul; C M Vandenbroucke-Grauls; D M Livermore
Journal: Antimicrob Agents Chemother Date: 2000-04 Impact factor: 5.191

10. Occurrence of extended-spectrum beta-lactamases in members of the family Enterobacteriaceae in Italy: implications for resistance to beta-lactams and other antimicrobial drugs.

Authors: T Spanu; F Luzzaro; M Perilli; G Amicosante; A Toniolo; G Fadda
Journal: Antimicrob Agents Chemother Date: 2002-01 Impact factor: 5.191

More extended-spectrum beta-lactamases.

1. TEM-E1: a novel beta-lactamase conferring resistance to ceftazidime.

2. In vivo selection of a cephamycin-resistant, porin-deficient mutant of Klebsiella pneumoniae producing a TEM-3 beta-lactamase.

3. Interactions of new plasmid-mediated beta-lactamases with third-generation cephalosporins.

4. Plasmid-mediated beta-lactamase (TEM-7) involved in resistance to ceftazidime and aztreonam.

5. Novel plasmid-mediated beta-lactamase from Escherichia coli that inactivates oxyimino-cephalosporins.

6. Characterization of the plasmid genes blaT-4 and blaT-5 which encode the broad-spectrum beta-lactamases TEM-4 and TEM-5 in enterobacteriaceae.

7. Plasmid-mediated beta-lactamases in clinical isolates of Klebsiella pneumoniae and Escherichia coli resistant to ceftazidime.

8. SHV-5, a novel SHV-type beta-lactamase that hydrolyzes broad-spectrum cephalosporins and monobactams.

9. Dissemination in five French hospitals of Klebsiella pneumoniae serotype K25 harbouring a new transferable enzymatic resistance to third generation cephalosporins and aztreonam.

Review 10. [Plasmid resistance to 3d generation cephalosporins].

1. In vitro and in vivo activities of amikacin, cefepime, amikacin plus cefepime, and imipenem against an SHV-5 extended-spectrum beta-lactamase-producing Klebsiella pneumoniae strain.

2. SHV-13, a novel extended-spectrum beta-lactamase, in Klebsiella pneumoniae isolates from patients in an intensive care unit in Amsterdam.

3. TEM-24 produced by four different species of Enterobacteriaceae, including Providencia rettgeri, in a single patient.

4. What's New in beta-lactamases?

5. An SHV-derived extended-spectrum beta-lactamase in Pseudomonas aeruginosa.

6. BetalasEN: microdilution panel for identifying beta-lactamases present in isolates of Enterobacteriaceae.

7. Binding properties of a peptide derived from beta-lactamase inhibitory protein.

8. Outbreak of infection with extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in a Mexican hospital.

Review 9. Plasmid-determined AmpC-type beta-lactamases.

10. Occurrence of extended-spectrum beta-lactamases in members of the family Enterobacteriaceae in Italy: implications for resistance to beta-lactams and other antimicrobial drugs.